Assessing the relationship of patient global assessment of disease activity and health related quality of life by SF-36 with other patient-reported outcomes in rheumatoid arthritis: post hoc analyses of data from phase 3 trials of baricitinib
| Main Authors: | , , , , , , |
|---|---|
| Format: | Conference item |
| Language: | English |
| Published: |
Journal of Rheumatology
2022
|
| _version_ | 1797108432940040192 |
|---|---|
| author | Strand, V Sebba, A Scardo, S Quebe, A Zaremba-Pechmann, L Taylor, P Sholter, D |
| author_facet | Strand, V Sebba, A Scardo, S Quebe, A Zaremba-Pechmann, L Taylor, P Sholter, D |
| author_sort | Strand, V |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T07:29:10Z |
| format | Conference item |
| id | oxford-uuid:993683c7-d01e-49e1-a2dd-321097820b5d |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T07:29:10Z |
| publishDate | 2022 |
| publisher | Journal of Rheumatology |
| record_format | dspace |
| spelling | oxford-uuid:993683c7-d01e-49e1-a2dd-321097820b5d2022-12-09T17:20:31ZAssessing the relationship of patient global assessment of disease activity and health related quality of life by SF-36 with other patient-reported outcomes in rheumatoid arthritis: post hoc analyses of data from phase 3 trials of baricitinibConference itemhttp://purl.org/coar/resource_type/c_c94fuuid:993683c7-d01e-49e1-a2dd-321097820b5dEnglishSymplectic ElementsJournal of Rheumatology2022Strand, VSebba, AScardo, SQuebe, AZaremba-Pechmann, LTaylor, PSholter, D |
| spellingShingle | Strand, V Sebba, A Scardo, S Quebe, A Zaremba-Pechmann, L Taylor, P Sholter, D Assessing the relationship of patient global assessment of disease activity and health related quality of life by SF-36 with other patient-reported outcomes in rheumatoid arthritis: post hoc analyses of data from phase 3 trials of baricitinib |
| title | Assessing the relationship of patient global assessment of disease activity and health related quality of life by SF-36 with other patient-reported outcomes in rheumatoid arthritis: post hoc analyses of data from phase 3 trials of baricitinib |
| title_full | Assessing the relationship of patient global assessment of disease activity and health related quality of life by SF-36 with other patient-reported outcomes in rheumatoid arthritis: post hoc analyses of data from phase 3 trials of baricitinib |
| title_fullStr | Assessing the relationship of patient global assessment of disease activity and health related quality of life by SF-36 with other patient-reported outcomes in rheumatoid arthritis: post hoc analyses of data from phase 3 trials of baricitinib |
| title_full_unstemmed | Assessing the relationship of patient global assessment of disease activity and health related quality of life by SF-36 with other patient-reported outcomes in rheumatoid arthritis: post hoc analyses of data from phase 3 trials of baricitinib |
| title_short | Assessing the relationship of patient global assessment of disease activity and health related quality of life by SF-36 with other patient-reported outcomes in rheumatoid arthritis: post hoc analyses of data from phase 3 trials of baricitinib |
| title_sort | assessing the relationship of patient global assessment of disease activity and health related quality of life by sf 36 with other patient reported outcomes in rheumatoid arthritis post hoc analyses of data from phase 3 trials of baricitinib |
| work_keys_str_mv | AT strandv assessingtherelationshipofpatientglobalassessmentofdiseaseactivityandhealthrelatedqualityoflifebysf36withotherpatientreportedoutcomesinrheumatoidarthritisposthocanalysesofdatafromphase3trialsofbaricitinib AT sebbaa assessingtherelationshipofpatientglobalassessmentofdiseaseactivityandhealthrelatedqualityoflifebysf36withotherpatientreportedoutcomesinrheumatoidarthritisposthocanalysesofdatafromphase3trialsofbaricitinib AT scardos assessingtherelationshipofpatientglobalassessmentofdiseaseactivityandhealthrelatedqualityoflifebysf36withotherpatientreportedoutcomesinrheumatoidarthritisposthocanalysesofdatafromphase3trialsofbaricitinib AT quebea assessingtherelationshipofpatientglobalassessmentofdiseaseactivityandhealthrelatedqualityoflifebysf36withotherpatientreportedoutcomesinrheumatoidarthritisposthocanalysesofdatafromphase3trialsofbaricitinib AT zarembapechmannl assessingtherelationshipofpatientglobalassessmentofdiseaseactivityandhealthrelatedqualityoflifebysf36withotherpatientreportedoutcomesinrheumatoidarthritisposthocanalysesofdatafromphase3trialsofbaricitinib AT taylorp assessingtherelationshipofpatientglobalassessmentofdiseaseactivityandhealthrelatedqualityoflifebysf36withotherpatientreportedoutcomesinrheumatoidarthritisposthocanalysesofdatafromphase3trialsofbaricitinib AT sholterd assessingtherelationshipofpatientglobalassessmentofdiseaseactivityandhealthrelatedqualityoflifebysf36withotherpatientreportedoutcomesinrheumatoidarthritisposthocanalysesofdatafromphase3trialsofbaricitinib |